Tempus AI Total Liabilities and Share Holders Equity 2023-2024 | TEM

Tempus AI total liabilities and share holders equity from 2023 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Tempus AI total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.972B, a INF% increase year-over-year.
  • Tempus AI total liabilities and share holders equity for 2023 was $0.564B, a 10.66% decline from 2022.
  • Tempus AI total liabilities and share holders equity for 2022 was $0.631B, a INF% increase from .
  • Tempus AI total liabilities and share holders equity for was $0B, a NAN% decline from .
Tempus AI Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $564
2022 $631
Tempus AI Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $972
2024-06-30 $865
2024-03-31 $469
2023-12-31 $564
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $631
Sector Industry Market Cap Revenue
Medical Medical Information Systems $8.497B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00